Mouse models of dengue virus infection and disease

被引:128
作者
Yauch, Lauren E. [1 ]
Shresta, Sujan [1 ]
机构
[1] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA
关键词
Flavivirus; Dengue virus; Mouse model; Vaccine; Antiviral therapy; Dengue fever; Dengue hemorrhagic fever/dengue shock syndrome;
D O I
10.1016/j.antiviral.2008.06.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dengue virus (DENV) causes the most significant mosquito-borne viral disease in the world in terms of illness, death, and economic cost, due to the lack of an approved vaccine or antiviral. Infections with one of the four serotypes of DENV (DENV1-4) can result in diseases ranging from an acute, self-limiting febrile illness (dengue fever, DF) to life-threatening dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS), yet exactly how viral and host factors contribute to the severe disease is unknown. Clinical observations have provided information on DENV pathogenesis, but the lack of an adequate animal model has hindered research on this important human pathogen. A mouse model is ideal for investigating host-pathogen interactions due to the immunological tools available, however, wild-type mice are resistant to DENV-induced disease. Therefore, the mouse models for DENV infection developed to date include infection of severely immunocompromised mice, non-physiologic routes of infection, and mouse-human chimeras. which all have their limitations. An inbred mouse model in which mice develop signs of human DENV-induced disease is needed to investigate the contribution of various immune components to protection and pathogenesis of DENV infections, and to test the efficacy of DENV vaccines and antivirals. (C) 2008 Elsevier B.V. All rights reserved
引用
收藏
页码:87 / 93
页数:7
相关论文
共 81 条
[51]   PROFILES OF ANTIBODY-DEPENDENT ENHANCEMENT OF DENGUE VIRUS TYPE-2 INFECTION [J].
MORENS, DM ;
HALSTEAD, SB ;
MARCHETTE, NJ .
MICROBIAL PATHOGENESIS, 1987, 3 (04) :231-237
[52]   MEASUREMENT OF ANTIBODY-DEPENDENT INFECTION ENHANCEMENT OF 4 DENGUE VIRUS SEROTYPES BY MONOCLONAL AND POLYCLONAL ANTIBODIES [J].
MORENS, DM ;
HALSTEAD, SB .
JOURNAL OF GENERAL VIROLOGY, 1990, 71 :2909-2914
[53]   A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties [J].
Olsen, DB ;
Eldrup, AB ;
Bartholomew, L ;
Bhat, B ;
Bosserman, MR ;
Ceccacci, A ;
Colwell, LF ;
Fay, JF ;
Flores, OA ;
Getty, KL ;
Grobler, JA ;
LaFemina, RL ;
Markel, EJ ;
Migliaccio, G ;
Prhavc, M ;
Stahlhut, MW ;
Tomassini, JE ;
MacCoss, M ;
Hazuda, DJ ;
Carroll, SS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) :3944-3953
[54]   Liver injury and viremia in mice infected with dengue-2 virus [J].
Paes, MV ;
Pinhao, AT ;
Barreto, DF ;
Costa, SM ;
Oliveira, MP ;
Nogueira, AC ;
Takiya, CM ;
Farias, JC ;
Schatzmayr, HG ;
Alves, AMB ;
Barth, OM .
VIROLOGY, 2005, 338 (02) :236-246
[55]   UNUSUAL NEUROLOGIC MANIFESTATIONS OCCURRING DURING DENGUE FEVER INFECTION [J].
PATEY, O ;
OLLIVAUD, L ;
BREUIL, J ;
LAFAIX, C .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1993, 48 (06) :793-802
[56]   Multiple specificities in the murine CD4(+) and CD8(+) T-cell response to dengue virus [J].
Rothman, AL ;
Kurane, I ;
Ennis, FA .
JOURNAL OF VIROLOGY, 1996, 70 (10) :6540-6546
[57]   PRODUCTION OF IMMUNITY TO DENGUE WITH VIRUS MODIFIED BY PROPAGATION IN MICE [J].
SABIN, AB ;
SCHLESINGER, RW .
SCIENCE, 1945, 101 (2634) :640-642
[58]  
SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
[59]   RISK-FACTORS IN DENGUE SHOCK SYNDROME - A PROSPECTIVE EPIDEMIOLOGIC-STUDY IN RAYONG, THAILAND .1. THE 1980 OUTBREAK [J].
SANGKAWIBHA, N ;
ROJANASUPHOT, S ;
AHANDRIK, S ;
VIRIYAPONGSE, S ;
JATANASEN, S ;
SALITUL, V ;
PHANTHUMACHINDA, B ;
HALSTEAD, SB .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1984, 120 (05) :653-669
[60]   EXPERIMENTAL-INFECTION OF CHIMPANZEES WITH DENGUE VIRUSES [J].
SCHERER, WF ;
RUSSELL, PK ;
ROSEN, L ;
CASALS, J ;
DICKERMAN, RW .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1978, 27 (03) :590-599